{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:50:55Z","timestamp":1793429455839,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monkeypox virus (MPXV) is the most pathogenic Poxvirus in circulation, yet key viral antigens remain immunologically unexplored. We isolate and characterize a panel of monoclonal antibodies (mAbs) targeting MPXV A28 (OPG153), an important membranal protein present on mature MPXV virions. From male convalescent individuals, we isolate anti-A28 mAbs alongside additional mAbs targeting the A35 and H3 proteins. Anti-A28 mAbs potently neutralize MPXV and Vaccinia virus (VACV) through complement-dependent mechanisms involving C1q and C3 deposition. High-resolution crystal structures of two anti-A28 mAbs, 10M2146 and 8M2110, in complex with VACV A26 reveal two distinct and highly conserved proximal epitopes within the N-terminal domain. Passive transfer of 8M2110 modestly attenuates disease in infected female mice. Moreover, immunization with A28 elicits antigen-specific B cells and robust neutralizing antibody responses and provides protection against lethal VACV challenge. These findings identify MPXV A28 as a promising central target for the induction of neutralizing antibodies and antiviral interventions.<\/jats:p>","DOI":"10.1038\/s41467-025-66344-0","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:25:56Z","timestamp":1765358756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Potent neutralization by antibodies targeting the MPXV A28 protein"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6001-4875","authenticated-orcid":false,"given":"Ron","family":"Yefet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Rakayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Guivel-Benhassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Rattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8995-3614","authenticated-orcid":false,"given":"Francoise","family":"Porrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Abramovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad","family":"Ostashinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Ben-Shalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Postal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-9008","authenticated-orcid":false,"given":"Ksenia","family":"Polonsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Ralph-Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sireen","family":"Sweed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Korner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Friedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4093-1032","authenticated-orcid":false,"given":"Eli","family":"Sprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Fishelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-3770","authenticated-orcid":false,"given":"Oren","family":"Kobiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-0625","authenticated-orcid":false,"given":"Lihi","family":"Adler-Abramovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-1475","authenticated-orcid":false,"given":"Olivier","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7292-5270","authenticated-orcid":false,"given":"Pablo","family":"Guardado-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5386-502X","authenticated-orcid":false,"given":"Natalia T.","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"66344_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","volume":"6","author":"N Sklenovska","year":"2018","unstructured":"Sklenovska, N. & Van Ranst, M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health 6, 241 (2018).","journal-title":"Front Public Health"},{"key":"66344_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-med-080122-030714","volume":"75","author":"JP Thornhill","year":"2024","unstructured":"Thornhill, J. P., Gandhi, M. & Orkin, C. Mpox: the reemergence of an old disease and inequities. Annu Rev. Med 75, 159\u2013175 (2024).","journal-title":"Annu Rev. Med"},{"key":"66344_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","volume":"58","author":"AM McCollum","year":"2014","unstructured":"McCollum, A. M. & Damon, I. K. Human monkeypox. Clin. Infect. Dis. 58, 260\u2013267 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"66344_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"FM Lum","year":"2022","unstructured":"Lum, F. M. et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat. Rev. Immunol. 22, 597\u2013613 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"66344_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40794-023-00209-6","volume":"9","author":"A Zebardast","year":"2023","unstructured":"Zebardast, A., Latifi, T., Shafiei-Jandaghi, N. Z., Gholami Barzoki, M. & Shatizadeh Malekshahi, S. Plausible reasons for the resurgence of Mpox (formerly Monkeypox): an overview. Trop. Dis. Travel Med Vaccines 9, 23 (2023).","journal-title":"Trop. Dis. Travel Med Vaccines"},{"key":"66344_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","volume":"350","author":"KD Reed","year":"2004","unstructured":"Reed, K. D. et al. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med 350, 342\u2013350 (2004).","journal-title":"N. Engl. J. Med"},{"key":"66344_CR7","unstructured":"World Health Organization. Multi-country outbreak of mpox, External situation report #42. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/emergencies\/20241109_mpox_external-sitrep_-42.pdf? sfvrsn=e7514f1b_1&download=true (2024)."},{"key":"66344_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.15585\/mmwr.mm7220a2","volume":"72","author":"JH McQuiston","year":"2023","unstructured":"McQuiston, J. H. et al. The CDC domestic mpox response - United States, 2022-2023. MMWR Morb. Mortal. Wkly Rep. 72, 547\u2013552 (2023).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"66344_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","volume":"29","author":"LM Zaeck","year":"2023","unstructured":"Zaeck, L. M. et al. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat. Med 29, 270\u2013278 (2023).","journal-title":"Nat. Med"},{"key":"66344_CR10","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/jama.2024.20951","volume":"332","author":"AY Collier","year":"2024","unstructured":"Collier, A. Y. et al. Decline of mpox antibody responses after modified vaccinia ankara-bavarian nordic vaccination. JAMA 332, 1669\u20131672 (2024).","journal-title":"JAMA"},{"key":"66344_CR11","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1016\/j.vaccine.2022.10.078","volume":"40","author":"L Priyamvada","year":"2022","unstructured":"Priyamvada, L. et al. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo. Vaccine 40, 7321\u20137327 (2022).","journal-title":"Vaccine"},{"key":"66344_CR12","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","volume":"388","author":"NP Deputy","year":"2023","unstructured":"Deputy, N. P. et al. Vaccine effectiveness of JYNNEOS against Mpox disease in the United States. N. Engl. J. Med 388, 2434\u20132443 (2023).","journal-title":"N. Engl. J. Med"},{"key":"66344_CR13","doi-asserted-by":"publisher","first-page":"126053","DOI":"10.1016\/j.vaccine.2024.06.021","volume":"42","author":"L Pischel","year":"2024","unstructured":"Pischel, L. et al. Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: a systematic review and meta-analysis. Vaccine 42, 126053 (2024).","journal-title":"Vaccine"},{"key":"66344_CR14","doi-asserted-by":"crossref","unstructured":"Crandell, J. et al. The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study. Lancet Microbe. 7, 101098. (2025).","DOI":"10.1016\/j.lanmic.2025.101098"},{"key":"66344_CR15","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1038\/s41591-024-03130-3","volume":"30","author":"EH Vakaniaki","year":"2024","unstructured":"Vakaniaki, E. H. et al. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo. Nat. Med 30, 2791\u20132795 (2024).","journal-title":"Nat. Med"},{"key":"66344_CR16","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S1473-3099(23)00352-3","volume":"23","author":"H Cohn","year":"2023","unstructured":"Cohn, H. et al. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study. Lancet Infect. Dis. 23, 1302\u20131312 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"66344_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41587-x","volume":"14","author":"AD Otter","year":"2023","unstructured":"Otter, A. D. et al. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals. Nat. Commun. 14, 5948 (2023).","journal-title":"Nat. Commun."},{"key":"66344_CR18","doi-asserted-by":"publisher","first-page":"105957","DOI":"10.1016\/j.isci.2023.105957","volume":"26","author":"R Yefet","year":"2023","unstructured":"Yefet, R. et al. Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens. iScience 26, 105957 (2023).","journal-title":"iScience"},{"key":"66344_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/v4050688","volume":"4","author":"B Moss","year":"2012","unstructured":"Moss, B. Poxvirus cell entry: how many proteins does it take? Viruses 4, 688\u2013707 (2012).","journal-title":"Viruses"},{"key":"66344_CR20","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","volume":"83","author":"GL Smith","year":"2002","unstructured":"Smith, G. L., Vanderplasschen, A. & Law, M. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83, 2915\u20132931 (2002).","journal-title":"J. Gen. Virol."},{"key":"66344_CR21","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1128\/jvi.66.7.4170-4179.1992","volume":"66","author":"R Blasco","year":"1992","unstructured":"Blasco, R. & Moss, B. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J. Virol. 66, 4170\u20134179 (1992).","journal-title":"J. Virol."},{"key":"66344_CR22","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","volume":"167","author":"I Gilchuk","year":"2016","unstructured":"Gilchuk, I. et al. Cross-neutralizing and protective human antibody specificities to poxvirus infections. Cell 167, 684\u2013694 e689 (2016).","journal-title":"Cell"},{"key":"66344_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-025-01280-1","volume":"14","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development. Infect. Dis. Poverty 14, 12 (2025).","journal-title":"Infect. Dis. Poverty"},{"key":"66344_CR24","doi-asserted-by":"publisher","unstructured":"Riccardo, V., & Pablo, G. C. Neutralization determinants on poxviruses. Viruses. https:\/\/doi.org\/10.3390\/v15122396. (2023).","DOI":"10.3390\/v15122396"},{"key":"66344_CR25","doi-asserted-by":"publisher","first-page":"199437","DOI":"10.1016\/j.virusres.2024.199437","volume":"347","author":"R Hou","year":"2024","unstructured":"Hou, R. et al. Identification of neutralizing antibodies against monkeypox virus using high-throughput sequencing of A35(+)H3L(+)B cells from patients with convalescent monkeypox. Virus Res 347, 199437 (2024).","journal-title":"Virus Res"},{"key":"66344_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48312-2","volume":"15","author":"R Zhao","year":"2024","unstructured":"Zhao, R. et al. Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections. Nat. Commun. 15, 4660 (2024).","journal-title":"Nat. Commun."},{"key":"66344_CR27","doi-asserted-by":"publisher","first-page":"e0159823","DOI":"10.1128\/spectrum.01598-23","volume":"11","author":"T Noy-Porat","year":"2023","unstructured":"Noy-Porat, T. et al. Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization. Microbiol Spectr. 11, e0159823 (2023).","journal-title":"Microbiol Spectr."},{"key":"66344_CR28","doi-asserted-by":"publisher","unstructured":"Meola, A. et al. Structural basis of poxvirus fusion regulation and anti-A16\/G9 antibody-mediated neutralization and protection. Cell https:\/\/doi.org\/10.1016\/j.cell.2025.07.040. (2025).","DOI":"10.1016\/j.cell.2025.07.040"},{"key":"66344_CR29","doi-asserted-by":"publisher","unstructured":"Ju, B. et al. Structurally conserved human anti-A35 antibodies protect mice and macaques from mpox virus infection. Cell https:\/\/doi.org\/10.1016\/j.cell.2025.08.005. (2025).","DOI":"10.1016\/j.cell.2025.08.005"},{"key":"66344_CR30","doi-asserted-by":"publisher","unstructured":"Fantin, R. F., et al. Human monoclonal antibodies targeting A35 protect from death caused by mpox. Cell https:\/\/doi.org\/10.1016\/j.cell.2025.08.004. (2025).","DOI":"10.1016\/j.cell.2025.08.004"},{"key":"66344_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47328-y","volume":"15","author":"H Tamir","year":"2024","unstructured":"Tamir, H. et al. Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection. Nat. Commun. 15, 3265 (2024).","journal-title":"Nat. Commun."},{"key":"66344_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3851\/IMP1573","volume":"15","author":"MM McCausland","year":"2010","unstructured":"McCausland, M. M. et al. Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model. Antivir. Ther. 15, 661\u2013675 (2010).","journal-title":"Antivir. Ther."},{"key":"66344_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58328-x","volume":"16","author":"W Tai","year":"2025","unstructured":"Tai, W. et al. An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses. Nat. Commun. 16, 2971 (2025).","journal-title":"Nat. Commun."},{"key":"66344_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1128\/CVI.00035-14","volume":"21","author":"C Pugh","year":"2014","unstructured":"Pugh, C., Keasey, S., Korman, L., Pittman, P. R. & Ulrich, R. G. Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000. Clin. Vaccin. Immunol. 21, 877\u2013885 (2014).","journal-title":"Clin. Vaccin. Immunol."},{"key":"66344_CR35","doi-asserted-by":"publisher","first-page":"e1007826","DOI":"10.1371\/journal.ppat.1007826","volume":"15","author":"HW Chang","year":"2019","unstructured":"Chang, H. W. et al. Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low pH. PLoS Pathog. 15, e1007826 (2019).","journal-title":"PLoS Pathog."},{"key":"66344_CR36","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1128\/JVI.00599-10","volume":"84","author":"SJ Chang","year":"2010","unstructured":"Chang, S. J., Chang, Y. X., Izmailyan, R., Tang, Y. L. & Chang, W. Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells. J. Virol. 84, 8422\u20138432 (2010).","journal-title":"J. Virol."},{"key":"66344_CR37","doi-asserted-by":"publisher","first-page":"e1009165","DOI":"10.1371\/journal.ppat.1009165","volume":"17","author":"M Mor","year":"2021","unstructured":"Mor, M. et al. Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors. PLoS Pathog. 17, e1009165 (2021).","journal-title":"PLoS Pathog."},{"key":"66344_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20930-0","volume":"12","author":"A Watson","year":"2021","unstructured":"Watson, A. et al. Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis. Nat. Commun. 12, 602 (2021).","journal-title":"Nat. Commun."},{"key":"66344_CR39","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003).","journal-title":"Science"},{"key":"66344_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbi.2023.06.020","volume":"113","author":"N Ben-Shalom","year":"2023","unstructured":"Ben-Shalom, N. et al. beta2-adrenergic signaling promotes higher-affinity B cells and antibodies. Brain Behav. Immun. 113, 66\u201382 (2023).","journal-title":"Brain Behav. Immun."},{"key":"66344_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79897-9","volume":"14","author":"S Imani","year":"2024","unstructured":"Imani, S. et al. Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions. Sci. Rep. 14, 29436 (2024).","journal-title":"Sci. Rep."},{"key":"66344_CR42","doi-asserted-by":"publisher","unstructured":"Ahmed, S. F., Sohail, M. S., Quadeer, A. A., and McKay, M. R. Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus. Viruses https:\/\/doi.org\/10.3390\/v14091960. (2022).","DOI":"10.3390\/v14091960"},{"key":"66344_CR43","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1126\/science.aah3945","volume":"353","author":"D Sok","year":"2016","unstructured":"Sok, D. et al. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice. Science 353, 1557\u20131560 (2016).","journal-title":"Science"},{"key":"66344_CR44","doi-asserted-by":"publisher","first-page":"e1005238","DOI":"10.1371\/journal.ppat.1005238","volume":"11","author":"NT Freund","year":"2015","unstructured":"Freund, N. T. et al. A new glycan-dependent CD4-binding site neutralizing antibody exerts pressure on HIV-1 In vivo. PLoS Pathog. 11, e1005238 (2015).","journal-title":"PLoS Pathog."},{"key":"66344_CR45","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1073\/pnas.1303682110","volume":"110","author":"L Scharf","year":"2013","unstructured":"Scharf, L. et al. Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody. Proc. Natl. Acad. Sci. USA 110, 6049\u20136054 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66344_CR46","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.chom.2023.05.001","volume":"31","author":"M Hubert","year":"2023","unstructured":"Hubert, M. et al. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals. Cell Host Microbe 31, 937\u2013948 e934 (2023).","journal-title":"Cell Host Microbe"},{"key":"66344_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.virol.2012.08.044","volume":"433","author":"Z Bengali","year":"2012","unstructured":"Bengali, Z., Satheshkumar, P. S. & Moss, B. Orthopoxvirus species and strain differences in cell entry. Virology 433, 506\u2013512 (2012).","journal-title":"Virology"},{"key":"66344_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46949-7","volume":"15","author":"S Monzon","year":"2024","unstructured":"Monzon, S. et al. Monkeypox virus genomic accordion strategies. Nat. Commun. 15, 3059 (2024).","journal-title":"Nat. Commun."},{"key":"66344_CR49","doi-asserted-by":"publisher","first-page":"e0149521","DOI":"10.1128\/mbio.01495-21","volume":"12","author":"TG Senkevich","year":"2021","unstructured":"Senkevich, T. G., Yutin, N., Wolf, Y. I., Koonin, E. V. & Moss, B. Ancient gene capture and recent gene loss shape the evolution of orthopoxvirus-host interaction genes. mBio 12, e0149521 (2021).","journal-title":"mBio"},{"key":"66344_CR50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","volume":"561","author":"P Mendoza","year":"2018","unstructured":"Mendoza, P. et al. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature 561, 479\u2013484 (2018).","journal-title":"Nature"},{"key":"66344_CR51","doi-asserted-by":"publisher","first-page":"12384","DOI":"10.1128\/JVI.01524-08","volume":"82","author":"AR Howard","year":"2008","unstructured":"Howard, A. R., Senkevich, T. G. & Moss, B. Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein. J. Virol. 82, 12384\u201312391 (2008).","journal-title":"J. Virol."},{"key":"66344_CR52","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/prot.21387","volume":"68","author":"EM Bublil","year":"2007","unstructured":"Bublil, E. M. et al. Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm. Proteins 68, 294\u2013304 (2007).","journal-title":"Proteins"},{"key":"66344_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","volume":"21","author":"JM Gershoni","year":"2007","unstructured":"Gershoni, J. M., Roitburd-Berman, A., Siman-Tov, D. D., Tarnovitski Freund, N. & Weiss, Y. Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs 21, 145\u2013156 (2007).","journal-title":"BioDrugs"},{"key":"66344_CR54","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1093\/bioinformatics\/btm493","volume":"23","author":"I Mayrose","year":"2007","unstructured":"Mayrose, I. et al. Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics 23, 3244\u20133246 (2007).","journal-title":"Bioinformatics"},{"key":"66344_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/nar\/gkl975","volume":"35","author":"I Mayrose","year":"2007","unstructured":"Mayrose, I. et al. Epitope mapping using combinatorial phage-display libraries: a graph-based algorithm. Nucleic Acids Res 35, 69\u201378 (2007).","journal-title":"Nucleic Acids Res"},{"key":"66344_CR56","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1128\/JVI.02152-12","volume":"87","author":"MR Benhnia","year":"2013","unstructured":"Benhnia, M. R. et al. Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine. J. Virol. 87, 1569\u20131585 (2013).","journal-title":"J. Virol."},{"key":"66344_CR57","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1128\/JVI.01797-08","volume":"83","author":"MR Benhnia","year":"2009","unstructured":"Benhnia, M. R. et al. Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. J. Virol. 83, 1201\u20131215 (2009).","journal-title":"J. Virol."},{"key":"66344_CR58","doi-asserted-by":"publisher","first-page":"e20597","DOI":"10.1371\/journal.pone.0020597","volume":"6","author":"ME Cohen","year":"2011","unstructured":"Cohen, M. E., Xiao, Y., Eisenberg, R. J., Cohen, G. H. & Isaacs, S. N. Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors. PLoS One 6, e20597 (2011).","journal-title":"PLoS One"},{"key":"66344_CR59","doi-asserted-by":"publisher","first-page":"e0101221","DOI":"10.1128\/JVI.01012-21","volume":"95","author":"J Holley","year":"2021","unstructured":"Holley, J. et al. Engineered promoter-switched viruses reveal the role of poxvirus maturation protein a26 as a negative regulator of viral spread. J. Virol. 95, e0101221 (2021).","journal-title":"J. Virol."},{"key":"66344_CR60","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","volume":"23","author":"DR Burton","year":"2023","unstructured":"Burton, D. R. Antiviral neutralizing antibodies: from in vitro to in vivo activity. Nat. Rev. Immunol. 23, 720\u2013734 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"66344_CR61","doi-asserted-by":"publisher","unstructured":"Freund, N. T. et al. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aal2144. (2017).","DOI":"10.1126\/scitranslmed.aal2144"},{"key":"66344_CR62","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","volume":"184","author":"N Suryadevara","year":"2021","unstructured":"Suryadevara, N. et al. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell 184, 2316\u20132331 e2315 (2021).","journal-title":"Cell"},{"key":"66344_CR63","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","volume":"453","author":"J Wrammert","year":"2008","unstructured":"Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667\u2013671 (2008).","journal-title":"Nature"},{"key":"66344_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0196-6553(82)90003-7","volume":"10","author":"MA Strassburg","year":"1982","unstructured":"Strassburg, M. A. The global eradication of smallpox. Am. J. Infect. Control 10, 53\u201359 (1982).","journal-title":"Am. J. Infect. Control"},{"key":"66344_CR65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","volume":"97","author":"A Volz","year":"2017","unstructured":"Volz, A. & Sutter, G. Modified vaccinia virus ankara: history, value in basic research, and current perspectives for vaccine development. Adv. Virus Res 97, 187\u2013243 (2017).","journal-title":"Adv. Virus Res"},{"key":"66344_CR66","doi-asserted-by":"publisher","first-page":"eadg3540","DOI":"10.1126\/scitranslmed.adg3540","volume":"15","author":"AW Freyn","year":"2023","unstructured":"Freyn, A. W. et al. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci. Transl. Med 15, eadg3540 (2023).","journal-title":"Sci. Transl. Med"},{"key":"66344_CR67","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","volume":"187","author":"EM Mucker","year":"2024","unstructured":"Mucker, E. M. et al. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell 187, 5540\u20135553 e5510 (2024).","journal-title":"Cell"},{"key":"66344_CR68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","volume":"25","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Rational design of a \u2018two-in-one\u2019 immunogen DAM drives potent immune response against mpox virus. Nat. Immunol. 25, 307\u2013315 (2024).","journal-title":"Nat. Immunol."},{"key":"66344_CR69","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani, A. et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187, 1363\u20131373 e1312 (2024).","journal-title":"Cell"},{"key":"66344_CR70","doi-asserted-by":"publisher","first-page":"eadl4317","DOI":"10.1126\/scitranslmed.adl4317","volume":"16","author":"C Jacob-Dolan","year":"2024","unstructured":"Jacob-Dolan, C. et al. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci. Transl. Med 16, eadl4317 (2024).","journal-title":"Sci. Transl. Med"},{"key":"66344_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54909-4","volume":"15","author":"Q Ye","year":"2024","unstructured":"Ye, Q. et al. A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates. Nat. Commun. 15, 10611 (2024).","journal-title":"Nat. Commun."},{"key":"66344_CR72","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.cell.2024.10.017","volume":"188","author":"E Kinganda-Lusamaki","year":"2025","unstructured":"Kinganda-Lusamaki, E. et al. Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018-2024: predominance of zoonotic transmission. Cell 188, 4\u201314 e16 (2025).","journal-title":"Cell"},{"key":"66344_CR73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41392-022-01181-x","volume":"7","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Li, M. & Fan, H. The monkeypox outbreak in 2022: adaptive evolution associated with APOBEC3 may account for. Signal Transduct. Target Ther. 7, 323 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"66344_CR74","doi-asserted-by":"publisher","first-page":"e0000923","DOI":"10.1128\/mra.00009-23","volume":"12","author":"C Baliere","year":"2023","unstructured":"Baliere, C. et al. Complete genome sequences of monkeypox virus from a french clinical sample and the corresponding isolated strain, obtained using nanopore sequencing. Microbiol Resour. Announc 12, e0000923 (2023).","journal-title":"Microbiol Resour. Announc"},{"key":"66344_CR75","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/S1473-3099(25)00014-3","volume":"25","author":"J Postal","year":"2025","unstructured":"Postal, J. et al. Antiviral activity of tecovirimat against monkeypox virus clades 1a, 1b, 2a, and 2b. Lancet Infect. Dis. 25, e126\u2013e127 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"66344_CR76","doi-asserted-by":"publisher","unstructured":"Cohen-Gihon, I. et al. Identification and whole-genome sequencing of a monkeypox virus strain isolated in Israel. Microbiol. Resour. Announc. https:\/\/doi.org\/10.1128\/MRA.01524-19. (2020).","DOI":"10.1128\/MRA.01524-19"},{"key":"66344_CR77","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1128\/JVI.02797-14","volume":"89","author":"L Qin","year":"2015","unstructured":"Qin, L., Favis, N., Famulski, J. & Evans, D. H. Evolution of and evolutionary relationships between extant vaccinia virus strains. J. Virol. 89, 1809\u20131824 (2015).","journal-title":"J. Virol."},{"key":"66344_CR78","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller, T. et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112\u2013124 (2008).","journal-title":"J. Immunol. Methods"},{"key":"66344_CR79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1006\/viro.1995.1378","volume":"211","author":"EJ Wolffe","year":"1995","unstructured":"Wolffe, E. J., Vijaya, S. & Moss, B. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology 211, 53\u201363 (1995).","journal-title":"Virology"},{"key":"66344_CR80","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","volume":"368","author":"HP Su","year":"2007","unstructured":"Su, H. P., Golden, J. W., Gittis, A. G., Hooper, J. W. & Garboczi, D. N. Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein. Virology 368, 331\u2013341 (2007).","journal-title":"Virology"},{"key":"66344_CR81","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jmb.2017.12.010","volume":"430","author":"J Ereno-Orbea","year":"2018","unstructured":"Ereno-Orbea, J. et al. Structural basis of enhanced crystallizability induced by a molecular chaperone for antibody antigen-binding fragments. J. Mol. Biol. 430, 322\u2013336 (2018).","journal-title":"J. Mol. Biol."},{"key":"66344_CR82","doi-asserted-by":"publisher","unstructured":"Bloch, J. S. et al Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins. Proc. Natl. Acad. Sci. USA. https:\/\/doi.org\/10.1073\/pnas.2115435118 (2021).","DOI":"10.1073\/pnas.2115435118"},{"key":"66344_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1107\/S0907444909047374","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr D. Biol. Crystallogr 66, 133\u2013144 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"66344_CR84","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl Crystallogr 40, 658\u2013674 (2007).","journal-title":"J. Appl Crystallogr"},{"key":"66344_CR85","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix. refine. Acta Crystallogr D. Biol. Crystallogr 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"66344_CR86","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"66344_CR87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."},{"key":"66344_CR88","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1128\/JVI.02933-15","volume":"90","author":"K Singh","year":"2016","unstructured":"Singh, K. et al. The vaccinia virus H3 envelope protein, a major target of neutralizing antibodies, exhibits a glycosyltransferase fold and binds UDP-Glucose. J. Virol. 90, 5020\u20135030 (2016).","journal-title":"J. Virol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66344-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:03:35Z","timestamp":1767020615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66344-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66344"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66344-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11455"}}